Analyst Ratings for Edwards Lifesciences (EW)
EW Rating Summary
EW Price Target Summary
- Highest: $117.00 (Janney Montgomery Scott)
- Lowest: $64.00 (UBS)
- Average: $92.13
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$92.13 (+40.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2013 | RBC Capital | Downgrade | Sector Perform (Outperform) |
72.00 (100.00) |
82.81 | 65.72 | -20.64% | Details |
| 4/24/2013 | Lazard Capital | Downgrade | Neutral (Buy) |
N/A (N/A) |
82.81 | 65.72 | -20.64% | Details |
| 2/1/2013 | Janney Montgomery Scott | New Coverage | Buy (N/A) |
117.00 (N/A) |
89.93 | 65.72 | -26.92% | Details |
| 1/4/2013 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
92.52 | 65.72 | -28.97% | Details |
| 11/20/2012 | Stifel Nicolaus | New Coverage | Buy (N/A) |
113.00 (N/A) |
85.03 | 65.72 | -22.71% | Details |
| 11/14/2012 | UBS » Updated 4/24/2013 |
Downgrade | Sell (Neutral) |
64.00 (N/A) |
87.75 | 65.72 | -25.11% | Details |
| 10/22/2012 | Citi | Downgrade | Neutral (Buy) |
N/A (N/A) |
86.14 | 65.72 | -23.71% | Details |
| 9/7/2012 | Northland Securities | Upgrade | Underperform (N/A) |
72.00 (N/A) |
106.82 | 65.72 | -38.48% | Details |
| 7/13/2012 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
100.82 | 65.72 | -34.81% | Details |
| 5/2/2012 | Wells Fargo | Upgrade | Outperform (N/A) |
104.00 (N/A) |
84.78 | 65.72 | -22.48% | Details |
| 1/19/2012 | Leerink Swann | New Coverage | Outperform (N/A) |
90.00 (N/A) |
77.68 | 65.72 | -15.4% | Details |
| 1/18/2012 | ThinkEquity | New Coverage | Buy (N/A) |
100.00 (N/A) |
72.25 | 65.72 | -9.04% | Details |
| 1/3/2012 | JPMorgan | Upgrade | Neutral (N/A) |
79.00 (N/A) |
70.70 | 65.72 | -7.04% | Details |
| 12/12/2011 | Canaccord Genuity » Updated 2/4/2013 |
Upgrade | Buy (N/A) |
115.00 (109.00) |
64.53 | 65.72 | 1.84% | Details |
| 9/23/2011 | Barclays » Updated 10/9/2012 |
Downgrade | Equalweight (N/A) |
85.00 (90.00) |
74.67 | 65.72 | -11.99% | Details |
